Amkor Technology (AMKR) executive files to sell $1.38M in common stock
Rhea-AI Filing Summary
Amkor Technology, Inc. insider Guillaume Rutten filed to potentially sell 25,000 shares of common stock of AMKR through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares have an indicated value of $1,383,765.00 and are listed on NASDAQ. The securities relate to Performance Shares dated 08/13/2024. In the past three months, Rutten reported a separate sale of 50,000 common shares on 05/08/2026 for proceeds of $3,713,965.00.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 25,000 shares
Indicated value of planned sale: $1,383,765.00
Past 3 months shares sold: 50,000 shares
+2 more
5 metrics
Planned shares to be sold
25,000 shares
Common stock indicated for sale under Form 144
Indicated value of planned sale
$1,383,765.00
Value of 25,000 AMKR common shares to be sold
Past 3 months shares sold
50,000 shares
Common shares sold on 05/08/2026
Value of past 3 months sale
$3,713,965.00
Proceeds from 50,000-share sale on 05/08/2026
Performance Shares date
08/13/2024
Date tied to the Performance Shares underlying the planned sale
Key Terms
Form 144, Performance Shares, Securities To Be Sold, Securities Sold During The Past 3 Months
4 terms
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities To Be Sold regulatory
"144: Securities To Be Sold"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 144 filing for AMKR by Guillaume Rutten disclose?
The filing discloses a potential sale of 25,000 AMKR common shares with an indicated value of $1,383,765.00, related to Performance Shares dated 08/13/2024, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.